Stifel Nicolaus Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $36.00

Surgery Partners (NASDAQ:SGRYGet Rating) had its price target decreased by Stifel Nicolaus from $44.00 to $36.00 in a research report report published on Tuesday, The Fly reports.

Other research analysts have also recently issued research reports about the stock. Royal Bank of Canada decreased their target price on shares of Surgery Partners from $62.00 to $58.00 and set an outperform rating for the company in a research report on Thursday, November 10th. SVB Leerink decreased their price objective on Surgery Partners from $55.00 to $40.00 and set an outperform rating for the company in a report on Tuesday. Cowen lowered their target price on Surgery Partners to $35.00 in a research report on Wednesday, November 16th. Citigroup reduced their price target on Surgery Partners from $49.00 to $38.00 and set a buy rating for the company in a research report on Wednesday, November 9th. Finally, StockNews.com lowered Surgery Partners from a hold rating to a sell rating in a report on Saturday, November 5th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company. According to MarketBeat, Surgery Partners presently has an average rating of Moderate Buy and a consensus target price of $49.22.

Surgery Partners Stock Up 2.3 %

Surgery Partners stock opened at $25.74 on Tuesday. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.07 and a current ratio of 1.18. Surgery Partners has a one year low of $20.46 and a one year high of $63.87. The company has a 50-day simple moving average of $26.10 and a 200-day simple moving average of $31.67. The firm has a market capitalization of $2.32 billion, a P/E ratio of -73.54 and a beta of 2.82.

Insider Activity

In other news, insider Laura L. Brocklehurst sold 4,338 shares of the company’s stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $22.96, for a total value of $99,600.48. Following the completion of the sale, the insider now owns 41,424 shares in the company, valued at $951,095.04. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, insider Laura L. Brocklehurst sold 4,338 shares of Surgery Partners stock in a transaction that occurred on Wednesday, November 9th. The shares were sold at an average price of $22.96, for a total value of $99,600.48. Following the transaction, the insider now owns 41,424 shares of the company’s stock, valued at approximately $951,095.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Brent Turner bought 10,000 shares of the company’s stock in a transaction that occurred on Monday, November 21st. The stock was acquired at an average price of $24.50 per share, for a total transaction of $245,000.00. Following the completion of the acquisition, the director now directly owns 57,701 shares in the company, valued at $1,413,674.50. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 4,671 shares of company stock worth $109,474. 3.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Surgery Partners

Several large investors have recently modified their holdings of SGRY. BNP Paribas Arbitrage SNC raised its position in shares of Surgery Partners by 83.8% during the third quarter. BNP Paribas Arbitrage SNC now owns 67,148 shares of the company’s stock worth $1,571,000 after purchasing an additional 30,617 shares during the period. Alliancebernstein L.P. increased its stake in Surgery Partners by 2.9% in the 3rd quarter. Alliancebernstein L.P. now owns 45,998 shares of the company’s stock worth $1,076,000 after purchasing an additional 1,300 shares in the last quarter. State Street Corp raised its holdings in Surgery Partners by 9.7% during the 3rd quarter. State Street Corp now owns 845,306 shares of the company’s stock worth $19,780,000 after buying an additional 74,801 shares during the period. Pier Capital LLC lifted its stake in Surgery Partners by 23.9% during the third quarter. Pier Capital LLC now owns 239,020 shares of the company’s stock valued at $5,593,000 after buying an additional 46,047 shares in the last quarter. Finally, Two Sigma Investments LP purchased a new stake in Surgery Partners during the third quarter valued at about $1,323,000.

Surgery Partners Company Profile

(Get Rating)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

See Also

The Fly logo

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.